Use este identificador para citar ou linkar para este item: http://www.repositorio.ufop.br/jspui/handle/123456789/15951
Título: Detection of drug resistant mycobacterium tuberculosis strains using Kit SIRE Nitratase® : a multicenter study.
Autor(es): Miranda, Silvana Spindola de
Almeida, Isabela Neves de
Mansur, Maria de Fátima Filardi Oliveira
Figueredo, Lida Jouca de Assis
Carvalho, Wânia da Silva
Hadaad, João Paulo Amaral
Diniz, Jaciara de Lourdes do Carmo Guimarães
Groll, Andrea von
Silva, Pedro Almeida da
Lopes, Maria Luiza
Santos, Marcelo Cordeiro dos
Brito, Alexandra
Mello, Fernanda Carvalho de Queiroz
Malaquias, Thiago da Silva Santos
Croda, Julio
Pinhata, Juliana Maira Watanabe
Oliveira, Rosângela Siqueira de
Chimara, Erica
Rossetti, Maria Lúcia
Halon, Maria Laura
Lourenço, Maria Cristina
Medeiros, Reginalda Ferreira de Melo
Montes, Fátima Cristina Onofre Fandinho
Machado, Diana
Viveiros, Miguel
Kritski, Afrânio Lineu
Palavras-chave: Multidrug resistant tuberculosis
Nitrate reductase
Technology
Data do documento: 2020
Referência: MIRANDA, S. S. de et al. Detection of drug resistant mycobacterium tuberculosis strains using Kit SIRE Nitratase®: a multicenter study. Brazilian Archives of Biology and Technology, v. 63, 2020. Disponível em: <https://www.scielo.br/j/babt/a/rwZ8F449jqmSRmgWcqgFdxc/?lang=en>. Acesso em: 11 out. 2022.
Resumo: (1) Background: The Commercial Kit SIRE Nitratase® PlastLabor, is a drug susceptibility test kit used to detect Mycobacterium tuberculosis resistance to first-line TB treatment drugs. The present study aimed at evaluating its performance in a multicenter study. (2) Methods: To determine its accuracy, the proportion methods in Lowenstein Jensen medium or the BACTECTMMGITTM960 system was used as a gold standard. (3) Results: The study revealed that the respective accuracies of the kit with 190 M. tuberculosis clinical isolates, using the proportion methods in Lowenstein Jensen medium or BACTECTMMGITTM960 system as a gold standard, were 93.9% and 94.6%, 96.9% and 94.6%, 98.0% and 97.8%, and 98.0% and 98.9%, for streptomycin, isoniazid, rifampicin, and ethambutol, respectively. (4) Conclusion: Thus, the kit can rapidly screen resistance to streptomycin, isoniazid, rifampicin, and ethambutol. Additionally, it does not require sophisticated equipment; hence, it can be easily used in the laboratories of low and middle income countries.
URI: http://www.repositorio.ufop.br/jspui/handle/123456789/15951
DOI: https://doi.org/10.1590/1678-4324-2020190179
ISSN: 1678-4324
Licença: Submitted for possible open access publication under the terms and conditions of the Creative Commons Attribution (CC BY NC) license (https://creativecommons.org/licenses/by-nc/4.0/). Fonte: o PDF do artigo.
Aparece nas coleções:DEACL - Artigos publicados em periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_DetectionDrugResistant.pdf242,23 kBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.